MX377921B - Proceso para la preparacion de (s)-2-((2-((s)-4-(difluorometil)-2-oxooxazolidin-3-il)-5,6-dihidrobenzo[f]imidazo[1,2-d] [1,4]oxazepin-9-il)amino)propanamida - Google Patents

Proceso para la preparacion de (s)-2-((2-((s)-4-(difluorometil)-2-oxooxazolidin-3-il)-5,6-dihidrobenzo[f]imidazo[1,2-d] [1,4]oxazepin-9-il)amino)propanamida

Info

Publication number
MX377921B
MX377921B MX2019006958A MX2019006958A MX377921B MX 377921 B MX377921 B MX 377921B MX 2019006958 A MX2019006958 A MX 2019006958A MX 2019006958 A MX2019006958 A MX 2019006958A MX 377921 B MX377921 B MX 377921B
Authority
MX
Mexico
Prior art keywords
oxooxazolidin
oxazepin
dihydrobenzo
propanamide
imidazo
Prior art date
Application number
MX2019006958A
Other languages
English (en)
Other versions
MX2019006958A (es
Inventor
Chong Han
Francis Gosselin
Scott Savage
Sean M Kelly
Theresa Cravillion
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2019006958A publication Critical patent/MX2019006958A/es
Publication of MX377921B publication Critical patent/MX377921B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Se describen métodos para fabricar compuestos de benzoxazepina oxazolidinona, así como los intermediarios sintéticos, incluido el compuesto 18, que tiene la estructura; (ver formula)
MX2019006958A 2016-12-15 2017-12-15 Proceso para la preparacion de (s)-2-((2-((s)-4-(difluorometil)-2-oxooxazolidin-3-il)-5,6-dihidrobenzo[f]imidazo[1,2-d] [1,4]oxazepin-9-il)amino)propanamida MX377921B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662434836P 2016-12-15 2016-12-15
PCT/EP2017/083143 WO2018109204A1 (en) 2016-12-15 2017-12-15 Process for the preparation of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino) propanamide

Publications (2)

Publication Number Publication Date
MX2019006958A MX2019006958A (es) 2019-08-01
MX377921B true MX377921B (es) 2025-03-10

Family

ID=61027659

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019006958A MX377921B (es) 2016-12-15 2017-12-15 Proceso para la preparacion de (s)-2-((2-((s)-4-(difluorometil)-2-oxooxazolidin-3-il)-5,6-dihidrobenzo[f]imidazo[1,2-d] [1,4]oxazepin-9-il)amino)propanamida
MX2020010948A MX2020010948A (es) 2016-12-15 2019-06-13 Proceso para la preparacion de (s)-2-((2-((s)-4-(difluorometil)-2- oxooxazolidin-3-il)-5,6-dihidrobenzo[f]imidazo[1,2-d] [1,4]oxazepin-9-il)amino)propanamida.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2020010948A MX2020010948A (es) 2016-12-15 2019-06-13 Proceso para la preparacion de (s)-2-((2-((s)-4-(difluorometil)-2- oxooxazolidin-3-il)-5,6-dihidrobenzo[f]imidazo[1,2-d] [1,4]oxazepin-9-il)amino)propanamida.

Country Status (17)

Country Link
US (1) US10781219B2 (es)
EP (2) EP3851441B1 (es)
JP (1) JP7004720B2 (es)
KR (1) KR102537048B1 (es)
CN (1) CN110088111B (es)
AR (1) AR110527A1 (es)
AU (2) AU2017378188B2 (es)
ES (2) ES2953833T3 (es)
HR (2) HRP20210592T1 (es)
HU (1) HUE062517T2 (es)
IL (2) IL267265B (es)
MX (2) MX377921B (es)
PL (2) PL3851441T3 (es)
SG (1) SG10201913961PA (es)
SI (1) SI3555107T1 (es)
TW (1) TWI770093B (es)
WO (1) WO2018109204A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111909173B (zh) 2015-07-02 2025-03-04 豪夫迈·罗氏有限公司 苯并氧氮杂䓬噁唑烷酮化合物及其使用方法
IL298518B2 (en) * 2017-04-28 2025-05-01 Hoffmann La Roche Polymorphs and solid forms of (S)–2–((2–((S–4–(difluoromethyl)–2–oxoxazolidin-3–yl)–5,6–dihydrobenzo[F]imidazo[1,2–D][1,4]oxazepin-9–yl)amino)propanamide and methods of preparation
WO2021041348A1 (en) 2019-08-26 2021-03-04 Arvinas Operations, Inc. Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders
CN113227101B (zh) * 2019-11-25 2024-10-11 上海翰森生物医药科技有限公司 含三并环类衍生物的盐或晶型及其药物组合物
CA3166087C (en) * 2020-03-03 2025-05-13 Momentive Performance Materials Inc. CATALYST COMPOSITION
KR20240013791A (ko) * 2021-05-28 2024-01-30 제넨테크, 인크. 벤족사제핀 옥사졸리디논 화합물을 제조하기 위한 공정
TW202440096A (zh) 2023-03-24 2024-10-16 美商亞文納營運公司 雌激素受體降解劑之給藥方案
TW202517655A (zh) * 2023-07-14 2025-05-01 瑞士商赫孚孟拉羅股份公司 使用[Cu(μ-salben)]錯合物之C-N偶合方法
KR20260049827A (ko) 2023-08-11 2026-04-14 에프. 호프만-라 로슈 아게 코팅 정제를 포함하는 약학적 제제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI423980B (zh) 2009-09-28 2014-01-21 Hoffmann La Roche 苯并氧氮呯pi3k抑制劑化合物及使用方法
KR20140032383A (ko) * 2011-03-21 2014-03-14 에프. 호프만-라 로슈 아게 Pi3k p110 델타에 대하여 선택적인 벤즈옥사제핀 화합물 및 이의 사용 방법
US9303043B2 (en) 2013-03-13 2016-04-05 Greentech, Inc. Process for making benzoxazepin compounds
CN111909173B (zh) * 2015-07-02 2025-03-04 豪夫迈·罗氏有限公司 苯并氧氮杂䓬噁唑烷酮化合物及其使用方法
IL298518B2 (en) 2017-04-28 2025-05-01 Hoffmann La Roche Polymorphs and solid forms of (S)–2–((2–((S–4–(difluoromethyl)–2–oxoxazolidin-3–yl)–5,6–dihydrobenzo[F]imidazo[1,2–D][1,4]oxazepin-9–yl)amino)propanamide and methods of preparation

Also Published As

Publication number Publication date
MX2020010948A (es) 2021-01-08
IL267265B (en) 2021-03-25
CN110088111A (zh) 2019-08-02
SI3555107T1 (sl) 2021-07-30
EP3851441B1 (en) 2023-06-28
AU2017378188B2 (en) 2020-11-26
US10781219B2 (en) 2020-09-22
BR112019010481A2 (pt) 2019-09-10
PL3555107T3 (pl) 2021-07-05
PL3851441T3 (pl) 2023-11-06
JP2020502143A (ja) 2020-01-23
HUE062517T2 (hu) 2023-11-28
AU2021201046A1 (en) 2021-03-11
EP3851441C0 (en) 2023-06-28
AR110527A1 (es) 2019-04-10
MX2019006958A (es) 2019-08-01
JP7004720B2 (ja) 2022-01-21
TW201837044A (zh) 2018-10-16
EP3555107B1 (en) 2021-02-17
US20190292201A1 (en) 2019-09-26
HRP20230948T1 (hr) 2023-11-24
IL281087A (en) 2021-04-29
KR102537048B1 (ko) 2023-05-26
EP3555107A1 (en) 2019-10-23
ES2867389T3 (es) 2021-10-20
CN110088111B (zh) 2021-08-03
IL267265A (en) 2019-08-29
HRP20210592T1 (hr) 2021-05-14
CA3044500A1 (en) 2018-06-21
SG10201913961PA (en) 2020-03-30
WO2018109204A1 (en) 2018-06-21
ES2953833T3 (es) 2023-11-16
KR20190093654A (ko) 2019-08-09
EP3851441A1 (en) 2021-07-21
AU2017378188A1 (en) 2019-05-30
TWI770093B (zh) 2022-07-11

Similar Documents

Publication Publication Date Title
MX2020010948A (es) Proceso para la preparacion de (s)-2-((2-((s)-4-(difluorometil)-2- oxooxazolidin-3-il)-5,6-dihidrobenzo[f]imidazo[1,2-d] [1,4]oxazepin-9-il)amino)propanamida.
WO2018029711A3 (en) Process for the preparation of venetoclax
IL267464A (en) Polymorphs and solid forms of (s)-2-((2-((s-4-(difluoromethyl)-2-oxoxolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][ 1,4]oxazepin-9-yl)amino)propanamide and methods of production
HK1246286A1 (zh) Lrrk2抑制剂及其制备和使用方法
WO2016063294A3 (en) Process for the preparation of (r)-3-(4-(7h-pyrrolo[2,3-d], pyrimidin-4-yl)-1 h-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate and its polymorphs thereof
ZA201805186B (en) Tlr7 agonist crystalline form a, preparation method and use thereof
EP3404032A3 (en) Process for making benzoxazepin compounds
HUE053455T2 (hu) Eljárás pirrolo[3,2-D]pirimidin vegyület elõállítására és intermedierjei
PH12020551465A1 (en) Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
MY185367A (en) Improved process for the preparation of osimertinib (azd9291) or a salt thereof, and ?azd9291 aniline? or a salt thereof
IL276483A (en) A continuous process for the preparation of trazodone
MX356804B (es) Polimorfos de 2-(4-(2-(1-isopropil-3-metil-1h-1,2,4-triazol-5-il)- 5,6-dihidrobenzo[f]imidazol[1,2-d][1,4]oxazepin-9-il)-1h-pirazol- 1-il)-2-metilpropanamida, metodos de produccion, y usos farmaceuticos de los mismos.
AU2018297073A1 (en) Process for the preparation of morphinane compounds
IL308457A (en) A process for preparing benzoxazepine oxazolidinone compounds
PT3601298T (pt) Processo para preparar compostos quirais de 2,3-dihidrotiazolo[ 3,2-a]pirimidina-4-ium
AU2018904171A0 (en) Process for preparing 2-substituted 3',4'-polyhydroxystilbene compounds
IN2014CH01257A (es)
HK40014282A (en) Methods for treating parkinson's disease